Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients.

Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients.

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in the United States with a five-year survival rate of 7.2% for all stages. Although surgical resection is the only curative treatment, currently we are unable to differentiate between resectable patients with occult metastati...

Full description

Bibliographic Details
Main Authors: Jayasree Chakraborty, Liana Langdon-Embry, Kristen M Cunanan, Joanna G Escalon, Peter J Allen, Maeve A Lowery, Eileen M O'Reilly, Mithat Gönen, Richard G Do, Amber L Simpson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5720792?pdf=render

Internet

http://europepmc.org/articles/PMC5720792?pdf=render

Similar Items